Healthscope shares are too cheap

Morgans Financial Limited

FY17 underlying results were below expectations, weighed down by continued soft conditions, cost pressures and volatile case mix in the core Hospital division. 
Increased competition and ramping VIC greenfields further pressured Hospital earnings, pushing it below expectations and guidance, and offsetting strong above market gains from brownfields, which remain on... Show More

Smart moves from BHP

Morgans Financial Limited

Investing in higher returning assets, moving to divest weak points, a newfound patience in its approach to capital deployment, the prospect of further capital management, and a recovering commodity cycle. BHP appears to be making smart moves. We retain our positive view, upgrade our share price target, and retain our... Show More

Ansell: Moving from Hold to Add

Morgans Financial Limited

We have modestly adjusted our FY18-20 earnings forecasts, lowering revenue and underlying earnings by up to 1.8%. Despite that, the Transformation program is now in train and we see the FY18 earnings guidance as conservative. Given that, we see upwards of 10% Return, and upgrade from Hold to Add. Show More

Orora: FY17 Result ahead of expectations

Morgans Financial Limited

Given another solid result, we become increasingly confident in Orora's (ORA) ability to execute on its growth strategy. This is despite a number of input cost headwinds in the Australiasia business and, in our view, shows the strength of the underlying business and the quality of the management team. Show More

A high-quality growth business

Morgans Financial Limited

PWR Holdings’ track record of delivering organic revenue growth is well demonstrated by its historical 3-year CAGR of 24% (FY13-16A). While currency headwinds and investments into resources (staff and equipment) will weigh on earnings in FY17, we believe the company is positioned well for strong growth in future years. Given... Show More